Using CEC levels to evaluate treatment outcomes of splanchnic vein thrombosis in chronic MPNs

Alessandro Lucchesi, MD, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS, Meldola, Italy, gives an overview of a study which used circulating endothelial cells (CECs) to evaluate treatment outcomes of splanchnic vein thrombosis in patients with chronic myeloproliferative neoplasms (MPNs). This interview took place at the XIII Eurasian Hematology-Oncology Congress (EHOC) held in Istanbul, Turkey.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.